4.7 Article

Delivery of Peptides to the Blood and Brain after Oral Uptake of Quaternary Ammonium Palmitoyl Glycol Chitosan Nanoparticles

Journal

MOLECULAR PHARMACEUTICS
Volume 9, Issue 6, Pages 1764-1774

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/mp300068j

Keywords

chitosan nanoparticles; nanoparticle oral uptake; chitosan amphiphiles; oral peptide delivery; quaternary ammonium palmitoyl glycol chitosan; GCPQ molecular weight; biodistribution; leucine(5)-enkephalin; CARS microscopy

Funding

  1. Engineering and Physical Sciences Research Council (EPSRC)
  2. GlaxoSmithKline (GSK)
  3. Engineering and Physical Sciences Research Council [EP/G061564/1, EP/G061483/1, EP/K502339/1, EP/K502340/1] Funding Source: researchfish
  4. EPSRC [EP/K502340/1, EP/G061564/1, EP/K502339/1, EP/G061483/1] Funding Source: UKRI

Ask authors/readers for more resources

The clinical development of therapeutic peptides has been restricted to peptides for non-CNS diseases and parenteral dosage forms due to the poor permeation of peptides across the gastrointestinal mucosa and the blood-brain barrier. Quaternary ammonium palmitoyl glycol chitosan (GCPQ) nanoparticles facilitate the brain delivery of orally administered peptides such as leucine(5)-enkephalin, and here we examine the mechanism of GCPQ facilitated oral peptide absorption and brain delivery. By analyzing the oral biodistribution of radiolabeled GCPQ nanoparticles, the oral biodistribution of the model peptide leucine(5)-enkephalin and coherent anti-Stokes Raman scattering microscopy tissue images after an oral dose of deuterated GCPQ nanoparticles, we have established a number of facts. Although 85-90% of orally administered GCPQ nanoparticles are not absorbed from the gastrointestinal tract, a peak level of 2-3% of the oral GCPQ dose is detected in the blood 30 min after dosing, and these GCPQ particles appear to transport the peptides to the blood. Additionally, although peptide loaded nanoparticles from low (6 kDa) and high (50 kDa) molecular weight GCPQ are taken up by enterocytes, polymer particles with a polymer molecular weight greater than 6 kDa are required to facilitate peptide delivery to the brain after oral administration. By examining our current and previous data, we conclude that GCPQ particles facilitate oral peptide absorption by protecting the peptide from gastrointestinal degradation, adhering to the mucus to increase the drug gut residence time and transporting GCPQ associated peptide across the enterocytes and to the systemic circulation, enabling the GCPQ stabilized peptide to be transported to the brain. Orally administered GCPQ particles are also circulated from the gastrointestinal tract to the liver and onward to the gall bladder, presumably for final transport back to the gastrointestinal tract.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

Amphotericin B Polymer Nanoparticles Show Efficacy against Candida Species Biofilms

Abdulghani Alakkad, Paul Stapleton, Corinna Schlosser, Sudaxshina Murdan, Uchechukwu Odunze, Andreas Schatzlein, Ijeoma F. Uchegbu

Summary: This study found that nanoparticulate amphotericin B (AmB) has strong activity against Candida biofilms and can penetrate the biofilm matrix and bind to fungal cells. MET-AmB eye drops were stable at room temperature, and these findings may help address refractory ocular fungal infections and other Candida biofilm infections.

PATHOGENS (2022)

Article Pharmacology & Pharmacy

Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes

Asya Petkova, Ilona Kubajewska, Alexandra Vaideanu, Andreas G. Schatzlein, Ijeoma F. Uchegbu

Summary: Gene delivery to the cerebral cortex can be achieved via intranasal administration of hyaluronidase-coated polyplexes (GCPH).

PHARMACEUTICS (2022)

Article Pharmacology & Pharmacy

Harnessing the Antibacterial Properties of Fluoridated Chitosan Polymers against Oral Biofilms

Dien Puji Rahayu, Roger Draheim, Aikaterini Lalatsa, Marta Roldo

Summary: Dental caries is a worldwide endemic chronic disease, and there is a need for new, effective, safe, and affordable oral products. A polymer (CS3H Lys F) has been found to have strong antibacterial properties and the ability to protect teeth from acid demineralization, making it a potential candidate for oral hygiene products.

PHARMACEUTICS (2022)

Review Chemistry, Multidisciplinary

Ultrasmall-in-Nano: Why Size Matters

Ryan D. Mellor, Ijeoma F. Uchegbu

Summary: This article reviews the applications of gold nanoparticles in the field of nanotechnology. By tuning the particle size, their physicochemical properties can be controlled, allowing for various applications in vivo. The effects of particle size on optical properties, opsonization, cellular internalization, renal clearance, biodistribution, tumor accumulation, and toxicity are discussed in detail.

NANOMATERIALS (2022)

Review Materials Science, Biomaterials

Traction of 3D and 4D Printing in the Healthcare Industry: From Drug Delivery and Analysis to Regenerative Medicine

Karim Osouli-Bostanabad, Tahereh Masalehdan, Robert M. I. Kapsa, Anita Quigley, Aikaterini Lalatsa, Kiara F. Bruggeman, Stephanie J. Franks, Richard J. Williams, David R. Nisbet

Summary: This article discusses the potential and challenges of 3D printing and 3D bioprinting in healthcare, highlighting their promise in the fields of regenerative medicine, tissue engineering, and drug delivery. The review emphasizes the customization and complexity of 3D-printed products, as well as the ability of 3D bioprinting to fabricate patient-specific tissues and living cell systems. It also discusses the importance of selecting appropriate printing methods and materials, and the potential of 4D-printed strategies to overcome limitations of conventional 3D printing technologies.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2022)

Review Pharmacology & Pharmacy

Microfluidic Manufacture of Lipid-Based Nanomedicines

Karim Osouli-Bostanabad, Sara Puliga, Dolores R. Serrano, Andrea Bucchi, Gavin Halbert, Aikaterini Lalatsa

Summary: Nanoparticulate technologies have revolutionized drug delivery, but their manufacture remains immature. Lipid-based nanomedicines are the most widely approved, but their current manufacturing methods are complex and not easily scalable. The emergence of microfluidic strategies has introduced a paradigm shift in the manufacturing of lipid-based nanomedicines, allowing for tunable and reproducible structure.

PHARMACEUTICS (2022)

Article Pharmacology & Pharmacy

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease

Miriam Rolon, Eustine Hanna, Celeste Vega, Cathia Coronel, Maria Auxiliadora Dea-Ayuela, Dolores R. Serrano, Aikaterini Lalatsa

Summary: Chagas disease is a parasitic zoonosis that is endemic in Central and South America, and current treatment options are limited. This study presents a new drug delivery system that allows for scalable combined formulations and can be easily converted to oral solid dosage form. The experimental results demonstrate promising efficacy of this new therapy.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Brain Gene Silencing with Cationic Amino-Capped Poly(ethylene glycol) Polyplexes

Abdullah A. Alamoudi, Paula A. Mendez, David Workman, Andreas G. Schatzlein, Ijeoma F. Uchegbu

Summary: Therapeutic gene silencing in the brain can be achieved through intranasal administration of siRNA-poly(ethylene glycol) based polyplexes. These polyplexes have low toxicity and can effectively silence specific genes in brain cells.

BIOMEDICINES (2022)

Review Pharmacology & Pharmacy

3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals

Dolores R. Serrano, Aytug Kara, Ivan Yuste, Francis C. C. Luciano, Baris Ongoren, Brayan J. J. Anaya, Gracia Molina, Laura Diez, Bianca I. I. Ramirez, Irving O. O. Ramirez, Sergio A. A. Sanchez-Guirales, Raquel Fernandez-Garcia, Liliana Bautista, Helga K. K. Ruiz, Aikaterini Lalatsa

Summary: 3D printing technologies offer customization of medicine to meet individual patients' needs. Various techniques such as nozzle-based extrusion, laser-writing systems, and powder binder jetting are used to print solid dosage forms, implants, stents, medical devices, and locally applied medicines. The challenge lies in selecting the appropriate 3D printing technique and pharmaceutical ink to ensure desired physicochemical and biological performance. Integration of biopharmaceuticals, nanotechnology-based drugs, and 3D printing opens up new possibilities for personalized nanomedicines. Continuous manufacturing using 3D-printed microfluidic chips facilitates translation into clinical practice.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform

Yvonne Lerchbammer-Kreith, Nadine S. Sommerfeld, Klaudia Cseh, Xian Weng-Jiang, Uchechukwu Odunze, Andreas G. Schaetzlein, Ijeoma F. Uchegbu, Mathea S. Galanski, Michael A. Jakupec, Bernhard K. Keppler

Summary: A new class of anticancer prodrugs was developed by combining platinum(IV) complexes with glycol chitosan polymers as drug carriers. The platinum(IV) complexes were synthesized and conjugated with degraded glycol chitosan (dGC) polymers of different chain lengths. These conjugates exhibited higher cytotoxicity and antiproliferative activity in cancer cell lines compared to platinum(IV) counterparts. In particular, a cisplatin(IV)-dGC conjugate showed the highest cytotoxicity, being 33 times more potent than the corresponding platinum(IV) complex and twice as potent as cisplatin. Biodistribution studies of an oxaliplatin(IV)-dGC conjugate also showed increased accumulation in the lung, suggesting potential for further activity studies.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis

Sarah Kymberly Santos de Lima, italo Novaes Cavallone, Dolores Remedios Serrano, Brayan J. Anaya, Aikaterini Lalatsa, Marcia Dalastra Laurenti, Joao Henrique Ghilardi Lago, Dalete Christine da Silva Souza, Gabriela Pustiglione Marinsek, Beatriz Soares Lopes, Renata de Britto Mari, Luiz Felipe Domingues Passero, Bozena B. Michniak-Kohn

Summary: This study developed a topical formulation containing 8-HQ and demonstrated its efficacy in experimental cutaneous leishmaniasis. The formulation was able to reduce parasite burden and lesion size without causing significant side effects.

PHARMACEUTICS (2023)

Review Materials Science, Biomaterials

Traction of 3D and 4D Printing in the Healthcare Industry: From Drug Delivery and Analysis to Regenerative Medicine

Karim Osouli-Bostanabad, Tahereh Masalehdan, Robert M. I. Kapsa, Anita Quigley, Aikaterini Lalatsa, Kiara F. Bruggeman, Stephanie J. Franks, Richard J. Williams, David R. Nisbet

Summary: This review explores the potential and applications of 3D printing and 3D bioprinting in healthcare, including the production of personalized products, patient-specific tissues, and organ-on-chip constructs. It also discusses how tailoring parameters and adopting dynamic 4D printing strategies can optimize and overcome limitations of conventional 3D printing technologies.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2022)

No Data Available